Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

Drug Treatment of Primary Insomnia: A Meta-Analysis of Polysomnographic Randomized Controlled Trials

(2014) Alexander Winkler et al.   CNS DRUGS

Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

(2014) L. Citrome   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

(2014) David Michelson et al.   LANCET NEUROLOGY

Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis

(2014) Akira Kuriyama et al.   SLEEP MEDICINE

LSN2424100: a novel, potent orexin-2 receptor antagonist with selectivity over orexin-1 receptors and activity in an animal model predictive of antidepressant-like efficacy

(2014) Thomas E. Fitch et al.   Frontiers in Neuroscience

Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep/wakefulness states in mice

(2014) Keishi Etori et al.   Frontiers in Neuroscience

OX1 and OX2 orexin/hypocretin receptor pharmacogenetics

(2014) Miles D. Thompson et al.   Frontiers in Neuroscience

Understanding the Sleep-Wake Cycle: Sleep, Insomnia, and the Orexin System

(2013) Andrew D. Krystal et al.   JOURNAL OF CLINICAL PSYCHIATRY

Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant

(2012) W. J. Herring et al.   NEUROLOGY

Benzodiazepines revisited-will we ever learn?

(2011) Malcolm Lader   ADDICTION

Benzodiazepine Use and Driving

(2009) Mark J. Rapoport et al.   JOURNAL OF CLINICAL PSYCHIATRY